|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 216.06 USD | -0.26% |
|
+9.57% | +22.77% |
| 06-29 | Biogen Inc.(NasdaqGS:BIIB) dropped from Russell 1000 Value-Defensive Index | CI |
| 06-29 | Biogen Inc.(NasdaqGS:BIIB) dropped from Russell 1000 Defensive Index | CI |
Company Valuation: Biogen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 35,242 | 39,877 | 37,495 | 22,283 | 25,818 | 31,983 | - | - |
| Change | - | 13.15% | -5.97% | -40.57% | 15.86% | 23.88% | - | - |
| Enterprise Value (EV) 1 | 37,820 | 40,560 | 43,384 | 26,204 | 28,289 | 37,355 | 35,332 | 32,295 |
| Change | - | 7.24% | 6.96% | -39.6% | 7.96% | 32.05% | -5.41% | -8.6% |
| P/E | 23.1x | 13.3x | 32.5x | 13.7x | 20x | 35x | 18.1x | 15.8x |
| PBR | 3.26x | 3.02x | 2.53x | 1.33x | 1.42x | 1.72x | 1.56x | 1.41x |
| PEG | - | 0x | -0.5x | 0.3x | -0.9x | -1.2x | 0.2x | 1.1x |
| Capitalization / Revenue | 3.21x | 3.92x | 3.81x | 2.3x | 2.61x | 3.18x | 3.08x | 2.99x |
| EV / Revenue | 3.44x | 3.99x | 4.41x | 2.71x | 2.86x | 3.72x | 3.4x | 3.02x |
| EV / EBITDA | 9.13x | 11.2x | 14.3x | 7.1x | 7.82x | 11.4x | 9.84x | 8.5x |
| EV / EBIT | 10.3x | 13.1x | 17x | 8.69x | 9.97x | 13.3x | 11x | 9.42x |
| EV / FCF | 11.2x | 35.5x | 34.2x | 9.63x | 13.8x | 14x | 13.6x | 13.4x |
| FCF Yield | 8.94% | 2.82% | 2.93% | 10.4% | 7.25% | 7.15% | 7.38% | 7.46% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 10.4 | 20.87 | 7.97 | 11.18 | 8.79 | 6.193 | 11.94 | 13.67 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 10,982 | 10,173 | 9,836 | 9,676 | 9,891 | 10,053 | 10,381 | 10,682 |
| EBITDA 1 | 4,144 | 3,618 | 3,040 | 3,689 | 3,618 | 3,272 | 3,589 | 3,799 |
| EBIT 1 | 3,656 | 3,099 | 2,545 | 3,015 | 2,838 | 2,812 | 3,206 | 3,430 |
| Net income 1 | 1,556 | 3,047 | 1,161 | 1,632 | 1,293 | 1,522 | 1,969 | 2,213 |
| Net Debt 1 | 2,578 | 683 | 5,888 | 3,921 | 2,471 | 5,372 | 3,350 | 312.3 |
| Reference price 2 | 239.92 | 276.92 | 258.77 | 152.92 | 175.99 | 216.63 | 216.63 | 216.63 |
| Nbr of stocks (in thousands) | 146,893 | 144,001 | 144,898 | 145,719 | 146,702 | 147,637 | - | - |
| Announcement Date | 2/3/22 | 2/15/23 | 2/13/24 | 2/12/25 | 2/6/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.98x | 3.72x | 11.41x | -.--% | 31.98B | |
| 16.36x | 3.55x | 9.58x | 0.62% | 64.28B | |
| 28.32x | 5.77x | 16.88x | 0.56% | 57.29B | |
| 35.89x | 12.16x | 23.03x | -.--% | 43.45B | |
| -56.58x | 3.05x | 9x | 3.59% | 38.02B | |
| -8.06x | 11.55x | -7.04x | -.--% | 27.66B | |
| 16.64x | 3.17x | 9.59x | -.--% | 22.91B | |
| 50.41x | 5.55x | 38.45x | -.--% | 17.74B | |
| 25.58x | 5.32x | 14.26x | -.--% | 16.45B | |
| -33.1x | 15.4x | -46.83x | -.--% | 14.1B | |
| Average | 11.04x | 6.92x | 7.83x | 0.48% | 33.39B | |
| Weighted average by Cap. | 12.60x | 6.34x | 10.70x | 0.62% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BIIB Stock
- Valuation Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
